Experienced in Chronic Obstructive Pulmonary Disease (COPD)

Marc Gainnier

Marseille, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Chronic Obstructive Pulmonary Disease (COPD)
Marseille, FR 
OverviewLocationsClinical Research

Overview

Marc Gainnier practices in Marseille, France. Mr. Gainnier is rated as an Experienced expert by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Hospital-Acquired Pneumonia, Systemic Capillary Leak Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Whipple Disease.

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Chronic Obstructive Pulmonary Disease (COPD).

Gender
Male

Locations

Marseille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Enrollment Status: Recruiting
Publish Date: August 05, 2025
Intervention Type: Drug
Study Drug: Levosimendan
Study Phase: Phase 3
A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Drug
Study Phase: Phase 3
C5a Receptor Expression in Circulating Myeloid Cells in ARDS Secondary to COVID-19
C5a Receptor Expression in Circulating Myeloid Cells in ARDS Secondary to COVID-19
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Other
Study Phase: Not Applicable
Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed Respiratory Failure in Hypoxemic Blunt Chest Trauma Patients.
Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed Respiratory Failure in Hypoxemic Blunt Chest Trauma Patients.
Enrollment Status: Completed
Publish Date: January 05, 2022
Intervention Type: Combination product
Study Phase: Not Applicable
Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.
Prevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.
Enrollment Status: Completed
Publish Date: August 14, 2019
Intervention Type: Other
Bronchoalveolar Lavages in the Intensive Care Unit : Indications, Adverse Respiratory Effects, Contribution to Diagnosis and Therapy. A Multicenter, Prospective, Observational Study
Bronchoalveolar Lavages in the Intensive Care Unit : Indications, Adverse Respiratory Effects, Contribution to Diagnosis and Therapy. A Multicenter, Prospective, Observational Study
Enrollment Status: Completed
Publish Date: May 23, 2019
Intervention Type: Procedure
View 5 Less Clinical Trials

55 Total Publications

Self-extubation in critically ill patients: from the French OUTCOMEREA Network.
Self-extubation in critically ill patients: from the French OUTCOMEREA Network.
Journal: Critical care (London, England)
Published: April 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gainnier's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile